Efficacy and Safety of Once-Weekly Semaglutide Monotherapy Versus Placebo in Patients With Type 2 Diabetes (SUSTAIN 1): A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multinational, Multicentre Phase 3a Trial

The Lancet Diabetes and Endocrinology - Netherlands
doi 10.1016/s2213-8587(17)30013-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy and Safety of Once-Weekly Semaglutide Versus Daily Canagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes (SUSTAIN 8): A Double-Blind, Phase 3b, Randomised Controlled Trial

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Efficacy and Safety of Teneligliptin Added Onto Canagliflozin Monotherapy in Japanese Patients With Type 2 Diabetes Mellitus: A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Comparative Study

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism
2018English

Efficacy and Safety of Analgesic Treatment for Depression in People With Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)

Drugs and Aging
GerontologyGeriatricsPharmacology
2018English

A Randomized, Placebo- And Sitagliptin-Controlled Trial of the Safety and Efficacy of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Japanese Patients With Type 2 Diabetes

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Protocol of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia (NICOFA)

Neurological Research and Practice
2019English

Efficacy and Safety of Praziquantel for the Treatment of Human Schistosomiasis During Pregnancy: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial

The Lancet Infectious Diseases
Infectious Diseases
2016English

Cyclosporin a Monotherapy Versus Cyclosporin a and Methotrexate Combination Therapy in Patients With Early Rheumatoid Arthritis: A Double Blind Randomised Placebo Controlled Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy